| Literature DB >> 11222810 |
R Van Koningsveld1, P A Van Doorn, P I Schmitz, F G Van der Meché.
Abstract
The authors assessed the referral pattern and outcome in patients with Guillain-Barré syndrome (n = 266) after the introduction of intravenous immunoglobulin (IVIg). Fewer patients were transferred from small to large hospitals after the introduction of IVIg (p = 0.05). This did not result in a worse outcome in patients treated in small centers. The introduction of IVIg has led to a better use of different levels of health care facilities.Entities:
Mesh：
Substances：
Year: 2001 PMID： 11222810 DOI： 10.1212/wnl.56.4.564
Source DB: PubMed Journal: Neurology ISSN： 0028-3878 Impact factor: 9.910